Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC

NCT02259595 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hearing Loss
Sensorineural Hearing Loss
Noise-Induced Hearing Loss

Interventions

DRUG: HPN-07
DRUG: NAC
DRUG: Placebo

Sponsor

Otologic Pharmaceutics, Inc.